Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival: A Never-Ending Debate

Lorenzo Azzalini; Mauro Carlino; Emmanouil S. Brilakis; Antonio Colombo

doi:10.1016/j.jcin.2016.03.017

Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival: A Never-Ending Debate

Lorenzo Azzalini, Mauro Carlino, Emmanouil S. Brilakis, Antonio Colombo

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	1198-1199
Number of pages	2
Journal	JACC: Cardiovascular Interventions
Volume	9
Issue number	11
DOIs	https://doi.org/10.1016/j.jcin.2016.03.017
State	Published - 2016

Access to Document

10.1016/j.jcin.2016.03.017

Cite this

@article{aec17b9af6534fbabd43f5362d35c983,

title = "Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival: A Never-Ending Debate",

author = "Lorenzo Azzalini and Mauro Carlino and Brilakis, {Emmanouil S.} and Antonio Colombo",

note = "Funding Information: Please note: Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, Asahi, Boston Scientific, Elsevier, Somahlution, St. Jude Medical, GE Healthcare, and Terumo; has received research grant support from InfraRedx and Boston Scientific; and has a spouse that is an employee of Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",

year = "2016",

doi = "10.1016/j.jcin.2016.03.017",

language = "English",

volume = "9",

pages = "1198--1199",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Does Chronic Total Occlusion Percutaneous Coronary Intervention Improve Survival

T2 - A Never-Ending Debate

AU - Azzalini, Lorenzo

AU - Carlino, Mauro

AU - Brilakis, Emmanouil S.

AU - Colombo, Antonio

N1 - Funding Information: Please note: Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, Asahi, Boston Scientific, Elsevier, Somahlution, St. Jude Medical, GE Healthcare, and Terumo; has received research grant support from InfraRedx and Boston Scientific; and has a spouse that is an employee of Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=84978289358&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2016.03.017

DO - 10.1016/j.jcin.2016.03.017

M3 - Letter

C2 - 27282606

AN - SCOPUS:84978289358

SN - 1936-8798

VL - 9

SP - 1198

EP - 1199

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 11

ER -